ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Michigan » Geriatric Medicine

Top Geriatric Medicine Prescribers in Michigan

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ADRIAN SHEREMETA M.D.

Geriatric Medicine

8,026

$413K

491
465 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $53

DENNIS PACKEY DO

Geriatric Medicine

7,609

$387K

230
165 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

28%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $53

LEONARD VANGELDER M.D.

Geriatric Medicine

7,584

$337K

516
245 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

46%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $53

SATISH KAMATH M.D.

Geriatric Medicine

7,397

$538K

378
359 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$73
Average prescription price

Avg: $53

ANTHONY HARRIS M.D.

Geriatric Medicine

6,934

$332K

253
150 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

31%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $53

ALIN SORA MD

Geriatric Medicine

6,887

$339K

334
281 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $53

ASMA AL-HAMID MD

Geriatric Medicine

6,794

$396K

427
390 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $53

MARC DENUCCIO D.O.

Geriatric Medicine

6,443

$437K

511
315 are 65+

2%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 20%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$68
Average prescription price

Avg: $53

RONALD PELAVIN M.D.

Geriatric Medicine

6,178

$436K

570
524 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$71
Average prescription price

Avg: $53

PANY DECOSSARD M.D.

Geriatric Medicine

6,116

$337K

287
216 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $53

ALAN DENGIZ M.D.

Geriatric Medicine

5,936

$381K

430
414 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 20%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $53

MICHELLE MANALAC MD

Geriatric Medicine

5,895

$328K

279
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $53

CATHERINE UPTON M.D.

Geriatric Medicine

5,670

$380K

245
240 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 20%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $53

GEORGE NASSIF MD

Geriatric Medicine

5,601

$265K

225
206 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

24%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $53

CHRISTINE SHINA M.D.

Geriatric Medicine

5,445

$352K

357
342 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $53

MYRIAM EDWARDS-MILLER M.D.

Geriatric Medicine

4,870

$315K

249
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $53

JUAN PEREZ M.D.

Geriatric Medicine

4,858

$211K

410
197 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

50%
patients receiving schedule three controlled substances

Avg: 20%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $53

BOONCHOO CHANG M.D.

Geriatric Medicine

4,824

$248K

282
161 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

29%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $53

RAZA HAQUE MD

Geriatric Medicine

4,661

$223K

165
151 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

29%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $53

NEAL PERSKY MD

Geriatric Medicine

4,649

$234K

233
229 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $53

HENRI GODBOLD M.D

Geriatric Medicine

4,611

$161K

364
156 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

34%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$35
Average prescription price

Avg: $53

CORNELIO NAGUIT M.D.

Geriatric Medicine

4,589

$271K

324
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $53

CHANDINI VALEESWARAN MD

Geriatric Medicine

4,177

$199K

581
542 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $53

LAVOISIER CARDOZO MD

Geriatric Medicine

4,100

$197K

338
313 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $53

MOHAMMAD TARIQ KANG MD

Geriatric Medicine

4,091

$149K

201
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $53

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank